Suxiang Chen

Mr. Suxiang Chen

Murdoch University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Theranostics
Verified
Journal Article
Open access
DYDongbin Yang
Dongbin Yang
WZWeihong Zhang
Weihong Zhang
HZHuanyun Zhang
Huanyun Zhang
FZFengqiu Zhang
Fengqiu Zhang
LCLanmei Chen
Lanmei Chen
TWTao Wang
Tao Wang
Exosomes are small extracellular vesicles with diameters of 30-150 nm. In both physiological and pathological conditions, nearly all types of cells can release exosomes, which play important roles in cell communication and epigenetic regulation by transporting crucial protein and genetic materials such as miRNA, mRNA, and DNA. Consequently, exosome-based disease diagnosis and therapeutic methods have been intensively investigated. However, as in any natural science field, the in-depth investigation of exosomes relies heavily on technological advances. Historically, the two main technical hindrances that have restricted the basic and applied researches of exosomes include, first, how to simplify the extraction and improve the yield of exosomes and, second, how to effectively distinguish exosomes from other extracellular vesicles, especially functional microvesicles. Over the past few decades, although a standardized exosome isolation method has still not become available, a number of techniques have been established through exploration of the biochemical and physicochemical features of exosomes. In this work, by comprehensively analyzing the progresses in exosome separation strategies, we provide a panoramic view of current exosome isolation techniques, providing perspectives toward the development of novel approaches for high-efficient exosome isolation from various types of biological matrices. In addition, from the perspective of exosome-based diagnosis and therapeutics, we emphasize the issue of quantitative exosome and microvesicle separation.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
TWTao Wang
Tao Wang
LCLanmei Chen
Lanmei Chen
ACArpitha Chikkanna
Arpitha Chikkanna
SCSuxiang Chen
Suxiang Chen
IBIsabell Brusius
Isabell Brusius
RVRakesh Naduvile Veedu
Rakesh Naduvile Veedu
Lateral flow assay (LFA) has made a paradigm shift in the in vitro diagnosis field due to its rapid turnaround time, ease of operation and exceptional affordability. Currently used LFAs predominantly use antibodies. However, the high inter-batch variations, error margin and storage requirements of the conventional antibody-based LFAs significantly impede its applications. The recent progress in aptamer technology provides an opportunity to combine the potential of aptamer and LFA towards building a promising platform for highly efficient point-of-care device development. Over the past decades, different forms of aptamer-based LFAs have been introduced for broad applications ranging from disease diagnosis, agricultural industry to environmental sciences, especially for the detection of antibody-inaccessible small molecules such as toxins and heavy metals. But commercial aptamer-based LFAs are still not used widely compared with antibodies. In this work, by analysing the key issues of aptamer-based LFA design, including immobilization strategies, signalling methods, and target capturing approaches, we provide a comprehensive overview about aptamer-based LFA design strategies to facilitate researchers to develop optimised aptamer-based LFAs.

20 October 2016 in RNA Biology
Verified
Journal Article
Open access
FLFarhana Lipi
Farhana Lipi
SCSuxiang Chen
Suxiang Chen
MCMadhuri Chakravarthy
Madhuri Chakravarthy
SRShilpa Rakesh
Shilpa Rakesh
RVRakesh Naduvile Veedu
Rakesh Naduvile Veedu
Nucleic acid aptamers are single-stranded DNA or RNA oligonucleotide sequences that bind to a specific target molecule with high affinity and specificity through their ability to adopt 3-dimensional structure in solution. Aptamers have huge potential as targeted therapeutics, diagnostics, delivery agents and as biosensors. However, aptamers composed of natural nucleotide monomers are quickly degraded in vivo and show poor pharmacodynamic properties. To overcome this, chemically-modified nucleic acid aptamers are developed by incorporating modified nucleotides after or during the selection process by Systematic Evolution of Ligands by EXponential enrichment (SELEX). This review will discuss the development of chemically-modified aptamers and provide the pros and cons, and new insights on in vitro aptamer selection strategies by using chemically-modified nucleic acid libraries.

22 January 2024 in BioDrugs
Verified
Journal Article
Open access
PDF file
SCSuxiang Chen
Suxiang Chen
SHSaumya Nishanga Heendeniya
Saumya Nishanga Heendeniya
BLBao T. Le
Bao T. Le
KRKamal Rahimizadeh
Kamal Rahimizadeh
NRNavid Rabiee
Navid Rabiee
RVRakesh Naduvile Veedu
Rakesh Naduvile Veedu
The last decade (2013–2023) has seen unprecedented successes in the clinical translation of therapeutic antisense oligonucleotides (ASOs). Eight such molecules have been granted marketing approval by the United States Food and Drug Administration (US FDA) during the decade, after the first ASO drug, fomivirsen, was approved much earlier, in 1998. Splice-modulating ASOs have also been developed for the therapy of inborn errors of metabolism (IEMs), due to their ability to redirect aberrant splicing caused by mutations, thus recovering the expression of normal transcripts, and correcting the deficiency of functional proteins. The feasibility of treating IEM patients with splice-switching ASOs has been supported by FDA permission (2018) of the first “N-of-1” study of milasen, an investigational ASO drug for Batten disease. Although for IEM, owing to the rarity of individual disease and/or pathogenic mutation, only a low number of patients may be treated by ASOs that specifically suppress the aberrant splicing pattern of mutant precursor mRNA (pre-mRNA), splice-switching ASOs represent superior individualized molecular therapeutics for IEM. In this work, we first summarize the ASO technology with respect to its mechanisms of action, chemical modifications of nucleotides, and rational design of modified oligonucleotides; following that, we precisely provide a review of the current understanding of developing splice-modulating ASO-based therapeutics for IEM. In the concluding section, we suggest potential ways to improve and/or optimize the development of ASOs targeting IEM.

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
NRNavid Rabiee
Navid Rabiee
SCSuxiang Chen
Suxiang Chen
SASepideh Ahmadi
Sepideh Ahmadi
RVRakesh Naduvile Veedu
Rakesh Naduvile Veedu
A diverse array of organic and inorganic materials, including nanomaterials, has been extensively employed in multifunctional biomedical applications. These applications encompass drug/gene delivery, tissue engineering, biosensors, photodynamic and photothermal therapy, and combinatorial sciences. Surface and bulk engineering of these materials, by incorporating biomolecules and aptamers, offers several advantages such as decreased cytotoxicity, improved stability, enhanced selectivity/sensitivity toward specific targets, and expanded multifunctional capabilities. In this comprehensive review, we specifically focus on aptamer-modified engineered materials for diverse biomedical applications. We delve into their mechanisms, advantages, and challenges, and provide an in-depth analysis of relevant literature references. This critical evaluation aims to enhance the scientific community's understanding of this field and inspire new ideas for future research endeavors.

18 February 2020 in BioTechniques
Verified
Journal Article
Open access
YLYalin Li
Yalin Li
SCSuxiang Chen
Suxiang Chen
Nan LiuNan Liu
Nan Liu
LMLixia Ma
Lixia Ma
TWTao Wang
Tao Wang
XJXumiao Jing
Xumiao Jing
Nucleic acid precipitation is important for virtually all molecular biology investigations. However, despite its crucial role, a systematic study of the influence factors of nucleic acid precipitat... METHOD SUMMARY To maximize the efficiency of nucleic acid precipitation, the key factors, including incubation and centrifugation conditions, and the volume ratio of polar solvents, cation-containi... Graphical abstract